Elinzanetant is an investigational, orally active dual neurokinin receptor antagonist currently under clinical development for the treatment of moderate to severe vasomotor symptoms associated with menopause . The therapeutic mechanism of Elinzanetant involves simultaneous antagonism of neurokinin-1 (NK-1) and neurokinin-3 (NK-3) receptors, which play key roles in the regulation of the hypothalamic-pituitary-gonadal axis and thermoregulation. By blocking these receptors, Elinzanetant modulates reproductive hormone secretion and reduces the frequency and severity of hot flashes and night sweats . The dual antagonism of Elinzanetant at NK-1 and NK-3 receptors also shows promise in research on neuropsychiatric disorders, including schizophrenia and sleep disorders . The well-characterized pharmacology of Elinzanetant has generated significant interest in both women's health and neuropsychiatric research.
|
Parameter |
Specification |
|
Product Name |
Elinzanetant |
|
CAS Number |
|
|
Molecular Formula |
|
|
Molecular Weight |
|
|
Appearance |
|
|
Density |
|
|
Boiling Point |
|
|
Storage Condition |
–20°C |
When your drug discovery program requires high-purity dual neurokinin receptor antagonists, Cosperpharm delivers Elinzanetant with the quality and consistency that pharmaceutical research demands.
Compound Integrity That Matters. The complex chiral structure and dual receptor binding of Elinzanetant requires the highest quality standards. Our analytical release protocol for Elinzanetant includes HPLC purity verification (>99%), identity confirmation, and stereochemical analysis, ensuring your research is built on a reliable foundation .
Documentation That Supports Your Research. Every shipment of Elinzanetant includes a Certificate of Analysis (COA) with batch-specific purity and characterization data, a Material Safety Data Sheet (SDS), and customs documentation for international delivery.
Flexible Supply for All Research Stages. Cosperpharm supplies Elinzanetant from milligram-scale quantities for in vitro research to gram-scale quantities for animal studies and formulation development.
Technical Expertise in Neurokinin Receptor Pharmacology. Our team can advise on solubility considerations, formulation strategies, and stability protocols for Elinzanetant, ensuring your research proceeds efficiently.
First-in-Class Dual NK-1/NK-3 Antagonist
Elinzanetant is a novel dual antagonist at both NK-1 and NK-3 receptors, offering a unique mechanism for modulating reproductive hormone secretion and thermoregulation .
Non-Hormonal Menopause Therapy
Elinzanetant offers a non-hormonal therapeutic approach for managing vasomotor symptoms in menopause, providing an alternative to hormone replacement therapy .
Well-Characterized in Vivo Profile
Elinzanetant has demonstrated significant efficacy in clinical studies, including reducing estradiol and progesterone levels and alleviating vasomotor symptoms .
High Purity for Research
Elinzanetant is available with ≥99% HPLC purity and comprehensive characterization, ensuring reliable and reproducible results .
Broad Research Applications
Beyond women's health, Elinzanetant shows promise in neuropsychiatric research, including schizophrenia, sleep disorders, and neuroendocrine regulation . Product Advantages
First-in-Class Dual NK-1/NK-3 Antagonist
Elinzanetant is a novel dual antagonist at both NK-1 and NK-3 receptors, offering a unique mechanism for modulating reproductive hormone secretion and thermoregulation .
Non-Hormonal Menopause Therapy
Elinzanetant offers a non-hormonal therapeutic approach for managing vasomotor symptoms in menopause, providing an alternative to hormone replacement therapy .
Well-Characterized in Vivo Profile
Elinzanetant has demonstrated significant efficacy in clinical studies, including reducing estradiol and progesterone levels and alleviating vasomotor symptoms .
High Purity for Research
Elinzanetant is available with ≥99% HPLC purity and comprehensive characterization, ensuring reliable and reproducible results .
Broad Research Applications
Beyond women's health, Elinzanetant shows promise in neuropsychiatric research, including schizophrenia, sleep disorders, and neuroendocrine regulation .
Q1: What is Elinzanetant used for?
A: Elinzanetant is a dual NK-1/NK-3 receptor antagonist under development for the treatment of menopause-associated vasomotor symptoms, including hot flashes and night sweats. It is also being researched for neuropsychiatric disorders .
Q2: What is the mechanism of action of Elinzanetant?
A: Elinzanetant acts as a dual antagonist of neurokinin-1 and neurokinin-3 receptors, modulating reproductive hormone secretion and thermoregulation pathways .
Looking for Elinzanetant to advance your women's health research or neuropsychiatric drug discovery program? Cosperpharm is your trusted partner for high-quality dual neurokinin receptor antagonists. Get in touch with our team today to discuss your requirements and request a quote.
Address
No. 2 Yangguang 3rd Road, Duodao Chemical Cycle Industrial Park, Jingmen City, Hubei Province, China
Tel
